GlassScriptPhysician profile
Mallory Brown
NPI 1275390817
$917.44
in general payments reported to CMS, 2019-2025
16 companies · $792 in 2025
The $792 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $125 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $222.24 | 2024-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $97.02 | 2024-2025 | Rexulti |
| Exact Sciences Corporation | $79.54 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $64.34 | 2025 | |
| Abbvie INC. | $62.39 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $51.97 | 2025 | Jornay Pm |
| Amgen INC. | $35.04 | 2025 | Krystexxa |
| Soleno Therapeutics, INC. | $34.70 | 2025 | Vykat Xr |
| Astrazeneca Pharmaceuticals LP | $30.41 | 2024-2025 | Airsupra, Breztri |
| Biogen, INC. | $27.21 | 2025 | Zurzuvae |
| Takeda Pharmaceuticals U.S.A., INC. | $25.34 | 2025 | Vpriv |
| Axsome Therapeutics, INC. | $17.25 | 2024 | Auvelity |
| Sanofi Pasteur INC. | $16.62 | 2025 | |
| Idorsia Pharmaceuticals US INC | $14.81 | 2024 | Quviviq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.56 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.